Mark A. Pilkinton

4.3k citations

23 papers · 835 indexed · h-index 15

Co-authors: O R Colamonici S. Mallal Raudel Sandoval Oscar R. Colamonici Wyatt J. McDonnell Spyros A. Kalams Gail Hecht Athanasia Koutsouris
Topics: Immune Cell Function and Interaction (6 papers)Cancer-related Molecular Pathways (5 papers)HIV Research and Treatment (4 papers)
Cited by: Virology Immunology Endocrinology
Journals: Journal of Biological Chemistry The Journal of Immunology Gastroenterology
Partner nations: United States Australia Haiti

In The Last Decade

Mark A. Pilkinton

22 papers receiving 830 citations

Peers

Countries citing papers authored by Mark A. Pilkinton

Since Specialization

Citations

This map shows the geographic impact of Mark A. Pilkinton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Pilkinton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Pilkinton more than expected).

Fields of papers citing papers by Mark A. Pilkinton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Pilkinton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Pilkinton. The network helps show where Mark A. Pilkinton may publish in the future.

Co-authorship network of co-authors of Mark A. Pilkinton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Pilkinton. A scholar is included among the top collaborators of Mark A. Pilkinton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Pilkinton. Mark A. Pilkinton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tracking of activated cTfh cells following sequential influenza vaccinations reveals transcriptional profile of clonotypes driving a vaccine-induced immune response 2023 ·Frontiers in Immunology ·(unknown),(unknown),(unknown),Silvana Gaudieri,(unknown),Rama Gangula,(unknown),Ramesh Ram,Shay Leary,(unknown),Rita M. Smith,Abha Chopra,Natasha Halasa,Mark A. Pilkinton,Spyros A. Kalams	0
2	The soluble epoxide hydrolase inhibitor GSK2256294 decreases the proportion of adipose pro-inflammatory T cells 2021 ·Prostaglandins & Other Lipid Mediators ·Mona Mashayekhi,Celestine N. Wanjalla,(unknown),(unknown),Kakali Ghoshal,Mark A. Pilkinton,Samuel Bailin,Curtis L. Gabriel,Ambra Pozzi,John R. Koethe,Nancy J. Brown,Spyros A. Kalams,James M. Luther	5
3	Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies 2021 ·Clinical Infectious Diseases ·Jonathan Z. Li,Evgenia Aga,Ronald J. Bosch,Mark A. Pilkinton,Eugène Kroon,(unknown),Michael C. Keefer,Lawrence Fox,Elizabeth Barr,Edward P. Acosta,Jintanat Ananworanich,Robert W. Coombs,John W. Mellors,Alan Landay,Bernard Macatangay,Steven G. Deeks,Rajesh T. Gandhi,Davey M. Smith	41
4	High Frequency of Shared Clonotypes in Human T Cell Receptor Repertoires 2020 ·Cell Reports ·Cinque Soto,Robin Bombardi,(unknown),Robert S. Sinkovits,Elaine C. Chen,Andre Branchizio,Nurgun Kose,Samuel B. Day,Mark A. Pilkinton,Madhusudan Gujral,S. Mallal,James E. Crowe	41
5	Group 2 Innate Lymphoid Cells Coordinate Damage Response in the Stomach 2020 ·Gastroenterology ·Anne R. Meyer,Amy C. Engevik,(unknown),(unknown),Matthew T. Stier,Allison E. Norlander,Mark A. Pilkinton,Wyatt J. McDonnell,Jared A. Weis,Bo Gun Jang,S. Mallal,R. Stokes Peebles,James R. Goldenring	64
6	The Proximal Airway Is a Reservoir for Adaptive Immunologic Memory in Idiopathic Subglottic Stenosis 2020 ·The Laryngoscope ·Alexander Gelbard,Celestine N. Wanjalla,Christopher T. Wootten,Wonder P. Drake,Anne S. Lowery,David A. Wheeler,Maria Cardenas,Andrew G. Sikora,Ravi Ramesh Pathak,Wyatt J. McDonnell,S. Mallal,Mark A. Pilkinton	17
7	Deep sequence analysis of HIV adaptation following vertical transmission reveals the impact of immune pressure on the evolution of HIV 2019 ·PLoS Pathogens ·(unknown),Abha Chopra,Mina John,Shay Leary,E. McKinnon,(unknown),Mark A. Pilkinton,Rita M. Smith,Louise Barnett,Wyatt J. McDonnell,Michaela Lucas,Francine Noël,S. Mallal,(unknown),Spyros A. Kalams,Silvana Gaudieri	18
8	Adipose Tissue in Persons With HIV Is Enriched for CD4+ T Effector Memory and T Effector Memory RA+ Cells, Which Show Higher CD69 Expression and CD57, CX3CR1, GPR56 Co-expression With Increasing Glucose Intolerance 2019 ·Frontiers in Immunology ·Celestine N. Wanjalla,Wyatt J. McDonnell,Louise Barnett,(unknown),(unknown),(unknown),Beverly Woodward,Run Fan,Fei Ye,(unknown),Ramesh Ram,Mark A. Pilkinton,Mona Mashayekhi,Nancy J. Brown,S. Mallal,Spyros A. Kalams,John R. Koethe	29
9	High CD8 T-Cell Receptor Clonality and Altered CDR3 Properties Are Associated With Elevated Isolevuglandins in Adipose Tissue During Diet-Induced Obesity 2018 ·Diabetes ·Wyatt J. McDonnell,John R. Koethe,S. Mallal,Mark A. Pilkinton,Annet Kirabo,Magdalene Ameka,Matthew A. Cottam,Alyssa H. Hasty,Arion Kennedy	42
10	Adipose Tissue is Enriched for Activated and Late-Differentiated CD8+ T Cells and Shows Distinct CD8+ Receptor Usage, Compared With Blood in HIV-Infected Persons 2017 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·John R. Koethe,Wyatt J. McDonnell,Arion Kennedy,Chike O. Abana,Mark A. Pilkinton,Ian Setliff,Ivelin S. Georgiev,Louise Barnett,(unknown),Rita M. Smith,Spyros A. Kalams,Alyssa H. Hasty,S. Mallal	23
11	Cytomegalovirus (CMV) Epitope–Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects 2017 ·The Journal of Immunology ·Chike O. Abana,Mark A. Pilkinton,Silvana Gaudieri,Abha Chopra,Wyatt J. McDonnell,Celestine N. Wanjalla,Louise Barnett,Rama Gangula,(unknown),Dae Kwang Jung,Brian G. Engelhardt,Madan Jagasia,Paul Klenerman,Elizabeth J. Phillips,David M. Koelle,Spyros A. Kalams,S. Mallal	36
12	Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion 2016 ·Vaccine ·Mark A. Pilkinton,(unknown),(unknown),Rita M. Smith,Sandra Yoder,H. Keipp Talbot,Spyros A. Kalams	46
13	CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli 2016 ·Circulation Research ·Hana A. Itani,Liang Xiao,Mohamed A. Saleh,Jing Wu,Mark A. Pilkinton,Bethany L. Dale,Natália R. Barbaro,Jason D. Foss,Annet Kirabo,Kim Ramil C. Montaniel,Allison E. Norlander,Wei Chen,Ryosuke Sato,L. Gabriel Navar,S. Mallal,Meena S. Madhur,Kenneth E. Bernstein,David G. Harrison	140
14	ARF-induced downregulation of Mip130/LIN-9 protein levels mediates a positive feedback that leads to increased expression of p16Ink4a and p19Arf 2010 ·Oncogene ·Ji‐Joon Song,(unknown),Mark A. Pilkinton,Xin Tian,Pradip Raychaudhuri,O R Colamonici	4
15	Deletion of the p107/p130-binding domain of Mip130/LIN-9 bypasses the requirement for CDK4 activity for the dissociation of Mip130/LIN-9 from p107/p130-E2F4 complex 2009 ·Experimental Cell Research ·Raudel Sandoval,Mark A. Pilkinton,Oscar R. Colamonici	14
16	Mip/LIN-9 can inhibit cell proliferation independent of the pocket proteins 2007 ·Blood Cells Molecules and Diseases ·Mark A. Pilkinton,Raudel Sandoval,Kelly M. Schiabor Barrett,Xinyong Tian,Oscar R. Colamonici	4
17	Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex 2007 ·Oncogene ·Mark A. Pilkinton,(unknown),O R Colamonici	96
18	A mutant allele of BARA/LIN-9 rescues the cdk4−/− phenotype by releasing the repression on E2F-regulated genes 2006 ·Experimental Cell Research ·Raudel Sandoval,Jiaping Xue,Xinyong Tian,Kelly M. Schiabor Barrett,Mark A. Pilkinton,David S. Ucker,Pradip Raychaudhuri,Rhonda D. Kineman,Raúl M. Luque,Gleb Baida,Xianghong Zou,V. E. Valli,James L. Cook,Hiroaki Kiyokawa,Oscar R. Colamonici	12
19	Mip/LIN-9 Regulates the Expression of B-Myb and the Induction of Cyclin A, Cyclin B, and CDK1 2006 ·Journal of Biological Chemistry ·Mark A. Pilkinton,Raudel Sandoval,(unknown),Scott A. Ness,Oscar R. Colamonici	50
20	Different Requirements for the Cytostatic and Apoptotic Effects of Type I Interferons 2004 ·Journal of Biological Chemistry ·Raudel Sandoval,Jiaping Xue,Mark A. Pilkinton,(unknown),Hiroaki Kiyokawa,Oscar R. Colamonici	43

About Mark A. Pilkinton

Mark A. Pilkinton is a scholar working on Virology, Aging and Immunology, having authored 23 papers that have together received 835 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), Cancer-related Molecular Pathways (5 papers) and HIV Research and Treatment (4 papers). The work is most often cited by research in Virology (86 citations), Immunology (255 citations) and Endocrinology (59 citations). Mark A. Pilkinton has collaborated with scholars based in United States, Australia and Haiti. Frequent co-authors include O R Colamonici, S. Mallal, Raudel Sandoval, Oscar R. Colamonici, Wyatt J. McDonnell, Spyros A. Kalams, Gail Hecht, Athanasia Koutsouris, V. K. Viswanathan and Ivana Simonović. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact